StockWatch
·
Pharmaceuticals
Business Update5 Sept 2026, 09:40 pm

Shukra Pharmaceuticals Releases Annual Report 2025-26

AI Summary

Shukra Pharmaceuticals Limited has released its Annual Report for the fiscal year 2025-26. The report, digitally signed by Dakshesh Rameshchandra Shah, details the company's performance and operations over the past year. The registered office is located at Dev House, Ahmedabad, Gujarat. The filing indicates a standard annual reporting procedure, providing stakeholders with comprehensive information on the company's financial health and strategic direction.

Key Highlights

  • Annual Report for FY 2025-26 has been published.
  • The report provides a comprehensive overview of company performance.
  • Stakeholders can review financial health and strategic direction.
  • Digital signature confirms authenticity of the filing.